We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Sensory Saturator Minimize Needle Injection Pain

By HospiMedica International staff writers
Posted on 20 Jan 2022
A simple, non-invasive, and drug free device instantly reduces needle injection pain and anxiety at a fraction of the cost of other methods.

The Bionix (Maumee, OH, USA) ShotBlocker is a washable plastic pad that uses an array of blunt contact points to saturate the sensory signals around an injection site, distracting patients from the pain signals of the needle by utilizing the Gate Theory of Pain. More...
The single-patient pad upholds a sterile environment during injection procedures, and also eliminates costs associated with resterilization, and is available in either 50 or 100 units per box. ShotBlocker is also available in a reusable form.

ShotBlocker blocks the pain of minor injections without using chemical refrigerant sprays, anesthetic creams, or electrical stimulation devices, and can be used for both intramuscular and subcutaneous injections. The device is positioned over the injection site, and the blunt contact points are pressed firmly against the skin. The shot is immediately administered through the central opening. After the injection, ShotBlocker is lifted from the skin and discarded, or given to the patient to retain until the next injection.

“I'm always trying to find solutions for patients to have the best experience in a medical setting. Getting shots can be scary, and sometimes painful, and I wanted to find a way to use science to make that experience better,” said James Huttner, MD, PhD, medical director and vice president of product development for Bionix, who invented the ShotBlocker. “If anxiety or pain is an obstacle for children to receive the COVID-19 vaccine, I think the ShotBlocker can make a real difference.”

The Gate Control theory of pain contends that non-painful inputs can override and reduce painful sensations, “shutting down” the final common pathway for sharp pain to the brain by exciting nerves that transmit cold and vibration senses, just as running a burn under cold water stops the sharp pain. The theory, proposed in 1965 by Ronald Melzack and Patrick Wall, offers a physiological explanation for the previously observed effect of psychology on pain perception.

Related Links:
Bionix


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Medical Adhesive
MED 5570U
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.